APA

Kobalava J. D., Gurevich V. S., Galyavich A. M., Kaminnyi A. I., Kashtalap V. V., Mareev V. Y., Susekov A. V. & Shaposhnik I. I. (20190709). [Possibilities of clinical use of ezetimibe Otrio (JSC "AKRIKHIN", Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts]. : Kardiologiia.

Chicago

Kobalava J D, Gurevich V S, Galyavich A M, Kaminnyi A I, Kashtalap V V, Mareev V Yu, Susekov A V and Shaposhnik I I. 20190709. [Possibilities of clinical use of ezetimibe Otrio (JSC "AKRIKHIN", Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts]. : Kardiologiia.

Harvard

Kobalava J. D., Gurevich V. S., Galyavich A. M., Kaminnyi A. I., Kashtalap V. V., Mareev V. Y., Susekov A. V. and Shaposhnik I. I. (20190709). [Possibilities of clinical use of ezetimibe Otrio (JSC "AKRIKHIN", Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts]. : Kardiologiia.

MLA

Kobalava J D, Gurevich V S, Galyavich A M, Kaminnyi A I, Kashtalap V V, Mareev V Yu, Susekov A V and Shaposhnik I I. [Possibilities of clinical use of ezetimibe Otrio (JSC "AKRIKHIN", Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts]. : Kardiologiia. 20190709.